Product
BBP-418
2 clinical trials
2 indications
Indication
Limb-Girdle Muscular Dystrophy Type 2IIndication
Limb-girdle muscular dystrophy type 2IClinical trial
A Phase 3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)Status: Recruiting, Estimated PCD: 2027-07-01
Clinical trial
An Open Label Phase 2 Study of BBP-418 in Patients With Limb Girdle Muscular Dystrophy Type 2I (MLB-01-003)Status: Active (not recruiting), Estimated PCD: 2026-11-01